Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title REVLIMID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HYDROXYZINE HYDROCHLORIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ABATACEPT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title EKTERLY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CREON
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SELADELPAR
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VERZENIO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VERZENIO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZEPBOUND KWIKPEN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SPRAVATO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PANTOPRAZOLE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title AMIODARONE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title KEVZARA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title MINOXIDIL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METFORMIN\SITAGLIPTIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OXALIPLATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title KETOCONAZOLE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METFORMIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LITHIUM
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title AMITRIPTYLINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FLECAINIDE ACETATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LANTUS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title MAGNESIUM SULFATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SERTRALINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DOXORUBICIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VALSARTAN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LIDOCAINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title MAGNESIUM SULFATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FASENRA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title AMITRIPTYLINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DUPIXENT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology